A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Pulmonx Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 159,010 shares of LUNG stock, worth $979,501. This represents 0.0% of its overall portfolio holdings.

Number of Shares
159,010
Previous 301,410 47.24%
Holding current value
$979,501
Previous $1.91 Million 30.99%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$5.59 - $8.58 $796,016 - $1.22 Million
-142,400 Reduced 47.24%
159,010 $1.32 Million
Q2 2024

Aug 09, 2024

BUY
$5.77 - $9.82 $200,795 - $341,736
34,800 Added 13.05%
301,410 $1.91 Million
Q1 2024

May 13, 2024

BUY
$8.71 - $14.65 $622,303 - $1.05 Million
71,447 Added 36.61%
266,610 $2.47 Million
Q4 2023

Feb 13, 2024

BUY
$7.89 - $13.14 $924,337 - $1.54 Million
117,153 Added 150.18%
195,163 $2.49 Million
Q3 2023

Nov 14, 2023

SELL
$9.88 - $14.0 $142,173 - $201,460
-14,390 Reduced 15.57%
78,010 $806,000
Q2 2023

Aug 11, 2023

SELL
$10.78 - $13.65 $1.1 Million - $1.4 Million
-102,445 Reduced 52.58%
92,400 $1.21 Million
Q1 2023

May 12, 2023

BUY
$7.49 - $12.54 $1.32 Million - $2.22 Million
176,803 Added 979.95%
194,845 $2.18 Million
Q4 2022

Feb 13, 2023

BUY
$4.92 - $17.35 $88,766 - $313,028
18,042 New
18,042 $152,000
Q2 2022

Aug 12, 2022

SELL
$14.0 - $27.95 $1.14 Million - $2.28 Million
-81,600 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$21.13 - $35.65 $1.52 Million - $2.56 Million
-71,700 Reduced 46.77%
81,600 $2.02 Million
Q4 2021

Feb 11, 2022

BUY
$29.72 - $45.1 $1.88 Million - $2.85 Million
63,200 Added 70.14%
153,300 $4.92 Million
Q3 2021

Nov 12, 2021

BUY
$35.98 - $44.48 $2.22 Million - $2.75 Million
61,800 Added 218.37%
90,100 $3.24 Million
Q2 2021

Aug 13, 2021

BUY
$37.61 - $48.0 $1.06 Million - $1.36 Million
28,300 New
28,300 $1.25 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $230M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.